Emerging Therapies for Acute and Chronic Heart Failure: Hope or Hype?
Although the period from 1953 to 2001 resulted in the approval of more than 30 medications currently used to treat heart failure (HF), few novel drugs have been approved in the last decade. However,...
View ArticleAn Update on the Management of Pulmonary Arterial Hypertension and the...
Pulmonary arterial hypertension (PAH) is a rare medical condition that significantly shortens life expectancy. The lack of understanding and complexity of treatments frequently lead to delays in...
View ArticleCritical Review and Update on the Treatment of Acute and Chronic Pulmonary...
Pulmonary embolism (PE), can be life-threatening without rapid appropriate therapy and often leads to chronic disease and disability. The ambiguity of symptoms makes PE difficult to diagnose, and...
View ArticleControversies Among the Hypertension Guidelines
Hypertension affects 80 million people in the United States. It remains poorly controlled, with only 54% of diagnosed patients treated to blood pressure targets. Hypertension management is complex in...
View ArticleClopidogrel Response Variability: Review of the Literature and Practical...
Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is standard therapy following acute coronary syndrome and percutaneous coronary intervention. Despite the use of potent antiplatelet agents,...
View ArticleDevice-Related Thrombosis in Continuous-Flow Left Ventricular Assist Device...
Advanced heart failure therapy has been revolutionized with the advent of continuous-flow ventricular assist devices (CF-LVADs) which have improved both survival and quality of life. Despite this,...
View ArticleCurrent Controversies With Recent Cholesterol Treatment Guidelines
Several guidelines and expert recommendations have been published recently regarding the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD) risk. The American College of...
View ArticleClinical Pearls in Using Antiarrhythmic Drugs in the Outpatient Setting
A role for oral antiarrhythmic drugs (AADs) remains in clinical practice for patients with atrial and ventricular arrhythmias in spite of advances in nonpharmacologic therapy. Pharmacists play a vital...
View Article
